Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For the satisfaction/information part of the study (parents or legal guardians):
- You are an expectant parent whose unborn child will receive care at one of the participating maternity units
- At least one parent or legal guardian has been given information about the study
- You are willing to allow your data to be used in the study
- You are covered by, or entitled to benefits from, a social security system
For the newborn genetic screening part of the study (babies):
- Your baby was born at one of the participating centers, or was born elsewhere but will be cared for at a participating center
- Your baby is less than 28 days old at the time the first screening sample (blotting paper) is collected
For the newborn genetic screening part of the study (parents or legal guardians):
- At least one biological parent has been given information about the study
- You do not object to standard newborn screening tests
- At least one parent or legal guardian is able to give consent for the baby to be tested
- At least one parent or legal guardian has signed a consent form
- The second parent or legal guardian has agreed to testing (unless they are unknown or cannot be contacted), as confirmed by the first parent or legal guardian
- You are covered by, or entitled to benefits from, a social security system
Who may not be able to join:
Parents or legal guardians:
- Parents or legal guardians who are under a legal protection order, such as guardianship or court-ordered supervision
Babies:
- Babies born under anonymous birth circumstances as defined by French law (known as "nés sous X")
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0380295313
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
parents who have accepted the pGS-NBS for their children for Treatable list; results concerning the Treatable list returned to clinicians within 4 weeks following the sample
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.